Invesaro

Stocks Health care AMRN

NASDAQ · Health care

Amarin Corp PLC (AMRN)

Amarin Corp PLC brought in $176.1M of revenue over the twelve months to September 30, 2026, down 22.3% from a year earlier. It posted a net loss of $19.1M. At September 30, 2026 it held $156.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 28, 2026.

Free, no password. An email when AMRN files with the SEC.

Price
$11.74
+1.12% on the day · November 9, 2026
52-week range $11.25 to $17.31
Market cap
$248M
Revenue (last 12 months)
$176.1M
-22.3% year on year
Net margin
-10.9%

Key facts about Amarin Corp PLC

Net worth
Amarin Corp PLC has a market value (market cap) of $248M at the latest share price, and shareholders' equity of $444.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $213.6M (-6.5% year on year), with a net loss of $38.8M. Over the 12 months to September 30, 2026: revenue $176.1M, net loss $19.1M.
Cash flow
In fiscal 2025 operations brought in $6.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 28, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Amarin Corp PLC's next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Amarin Corp PLC does

Amarin Corp PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker AMRN.

Revenue and profit by year

Revenue
FY18: $229.2M $229.2M FY18FY19: $429.8M $429.8M FY19FY20: $614.1M $614.1M FY20FY21: $583.2M $583.2M FY21FY22: $369.2M $369.2M FY22FY23: $306.9M $306.9M FY23FY24: $228.6M $228.6M FY24FY25: $213.6M $213.6M FY25
Net income
FY18: -$116.4M -$116.4M FY18FY19: -$22.6M -$22.6M FY19FY20: -$18M -$18M FY20FY21: $7.7M $7.7M FY21FY22: -$105.8M -$105.8M FY22FY23: -$59.1M -$59.1M FY23FY24: -$82.2M -$82.2M FY24FY25: -$38.8M -$38.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$213.6M-$50.2M-$38.8M-$0.09n/a
2024$228.6M-$91.8M-$82.2M-$0.20n/a
2023$306.9M-$67.6M-$59.1M-$0.15n/a
2022$369.2M-$105.9M-$105.8M-$0.26n/a
2021$583.2M$10.5M$7.7M$0.02n/a
2020$614.1M-$19.7M-$18M-$0.05-$22M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around January 7, 2027.

Estimated from its filing rhythm: 52 weeks after its report of January 8, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where AMRN ranks in Health care

Revenue$213.6M
#268 of 751 in Health care · Top 36%
Revenue growth-6.5%
#460 of 532 in Health care · Bottom 14%
Net margin-18.2%
#316 of 544 in Health care · Bottom 42%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Amarin Corp PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 28, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue fell 20% to $39.6M versus the same quarter last year; diluted EPS $0.00 versus -$0.02.
  2. October 28, 2026
  3. August 27, 2026
  4. July 29, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 42% to $42.2M versus the same quarter last year; diluted EPS -$0.02 versus -$0.03.
  5. July 29, 2026
  6. May 15, 2026
  7. April 29, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 7.4% to $45.1M versus the same quarter last year; diluted EPS -$0.03 versus -$0.04.
  8. April 29, 2026
  9. April 10, 2026
  10. April 10, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 3, 2026. Insider transactions on SEC

Insider trades

What the people running Amarin Corp PLC did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 1, 2026 Fishman Peter L.SVP, CFO Exercised options 313 - - Form 4
August 1, 2026 Fishman Peter L.SVP, CFO Shares withheld for tax 155 $14.26 $2.2K Form 4
July 1, 2026 Provoost JonathanEVP, Chief Legal Officer Exercised options 3,688 - - Form 4
July 1, 2026 Provoost JonathanEVP, Chief Legal Officer Shares withheld for tax 1,264 $15.94 $20.1K Form 4
July 1, 2026 Ketchum Steven BEVP, Chief Scientific Officer Exercised options 3,688 - - Form 4
July 1, 2026 Ketchum Steven BEVP, Chief Scientific Officer Shares withheld for tax 1,887 $15.94 $30.1K Form 4
July 1, 2026 Keenan David PaulEVP, Chief Operating Officer Exercised options 3,688 - - Form 4
July 1, 2026 Keenan David PaulEVP, Chief Operating Officer Shares withheld for tax 1,926 $15.94 $30.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns AMRN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Sarissa Capital Management LP13D, may seek influence with 1 related filers 6.09% 25,743,900 August 27, 2026

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 1 managers reported a position.

HolderSharesValueChange on quarter
Winch Advisory Services, LLC7$1120

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

12 insiders reported holding 170,532 shares in total, about $2M at the last price.

HolderSharesAs of
Berg AaronPresident and CEO 85,648 June 26, 2026
Ketchum Steven BEVP, Chief Scientific Officer 42,680 July 1, 2026
Fishman Peter L.SVP, CFO 15,080 August 1, 2026
Keenan David PaulEVP, Chief Operating Officer 13,470 July 1, 2026
Provoost JonathanEVP, Chief Legal Officer 4,624 July 1, 2026
Sterling Louis IIIDirector 4,049 April 18, 2026
Cohen PaulDirector 836 April 18, 2026
Bonfiglio Patrice EadonDirector 836 April 18, 2026
Sullivan Diane E.Director 836 April 18, 2026
Odysseas Kostas DDirector 836 April 18, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about AMRN

What does Amarin Corp PLC do?

Amarin Corp PLC is a company in the Health care sector, listed on NASDAQ as AMRN. Its shares trade on NASDAQ under the ticker AMRN.

What is Amarin Corp PLC's net worth?

Amarin Corp PLC has a market value (market cap) of $248M at the latest share price, and shareholders' equity of $444.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Amarin Corp PLC profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $19.1M on revenue of $176.1M.

How much revenue does Amarin Corp PLC make?

Over the twelve months to September 30, 2026 Amarin Corp PLC reported revenue of $176.1M. That is 22.3% less than a year earlier.

When did Amarin Corp PLC last report?

Its most recent periodic report is the quarterly report (10-Q) filed on October 28, 2026. It covers the period to September 30, 2026.

When is Amarin Corp PLC's next earnings report?

Amarin Corp PLC's next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare AMRN with

Compare AMRN with any company

Follow AMRN

Get an email when Amarin Corp PLC files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when AMRN files with the SEC.

Where the numbers come from

Financial figures are the values Amarin Corp PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.